Welcome to our dedicated page for Advansix news (Ticker: ASIX), a resource for investors and traders seeking the latest updates and insights on Advansix stock.
Advansix Inc. (ASIX) is a leading integrated manufacturer of nylon solutions and diversified chemical products serving industrial and agricultural markets worldwide. This news hub provides investors and industry professionals with authoritative updates on corporate developments, financial performance, and operational milestones.
Access timely announcements including quarterly earnings reports, production innovations, and strategic partnerships. Our curated collection features official press releases alongside verified third-party analysis covering ASIX's advancements in caprolactam production, plant nutrition solutions, and specialty chemical applications.
Key content categories include manufacturing capacity updates from facilities in Virginia and Pennsylvania, R&D breakthroughs in polymer chemistry, and market expansion initiatives. Track regulatory compliance developments and sustainability efforts shaping Advansix's position in global supply chains.
Bookmark this page for streamlined access to material disclosures affecting ASIX investment considerations. Check regularly for updates on operational efficiencies, product certifications, and leadership announcements from this NYSE-listed chemical industry innovator.
AdvanSix (NYSE: ASIX) appointed Jeffrey J. Bird to its Board of Directors, effective January 1, 2026. With his appointment the Board will total 10 members, including nine independent directors. Mr. Bird is currently Interim President and COO of Envent Corporation and serves on the board of Heath Consultants. He previously held senior finance and operating roles including President and CEO of Dril-Quip, EVP & CFO of Frank’s International, and VP Finance/CFO at Ascend Performance Materials, and holds a BA in Accounting from Cedarville University.
Mr. Bird will join the Audit Committee and the Health, Safety and Environmental Committee. Company leadership said his financial and operational experience will support governance, safety-focused operations and efforts to drive long-term shareholder value.
AdvanSix (NYSE: ASIX) reported 3Q25 sales of $374.5M, down ~6% year‑over‑year, and a net loss of $2.6M (diluted EPS $(0.10)); adjusted EPS $0.08. Adjusted EBITDA was $24.7M with an adjusted EBITDA margin of 6.6%. Cash flow from operations was $26.6M, capital expenditures were $26.5M, and free cash flow was approximately $66k.
The company expects 2025 capex of $120–$125M, sees continued strength in Plant Nutrients, is moderating nylon production, and declared a quarterly dividend of $0.16 payable Dec 2, 2025.
AdvanSix (NYSE: ASIX) will release its third quarter 2025 financial results before the opening of the New York Stock Exchange on Friday, November 7, 2025. The company will host an investor conference call at 9:30 a.m. ET the same day.
Dial-in details: domestic (844) 855-9494, international (412) 858-4602; join ~10 minutes early and identify yourself for AdvanSix’s Q3 2025 earnings call. A replay will be available from 12:00 noon ET on Nov 7 until 12:00 noon ET on Nov 14 via domestic (877) 344-7529 or international (412) 317-0088; access code 9358968. A real-time audio webcast and related presentation materials will be available at http://investors.advansix.com, with a webcast replay posted after the presentation.
AdvanSix (NYSE: ASIX) has strengthened its Board of Directors with the appointment of two new independent members: Dana O'Brien, former Senior VP and Chief Legal Officer of Olin Corporation, and Daryl Roberts, current Senior VP and Chief Operations and Engineering Officer of DuPont de Nemours.
O'Brien will serve on the Nominating and Governance Committee and the Compensation and Leadership Development Committee, while Roberts will join the Health, Safety and Environmental Committee and the Compensation and Leadership Development Committee. With these additions, AdvanSix's Board now comprises nine members, including eight independent directors.
The appointments reflect AdvanSix's commitment to enhancing corporate governance and strategic oversight as the company focuses on delivering long-term earnings growth and shareholder value as a diversified chemistry company.
AdvanSix (NYSE: ASIX) reported Q2 2025 financial results with sales of $410 million, down 10% year-over-year. The company posted earnings per share of $1.15 and adjusted EPS of $1.24, including $8 million in 45Q carbon capture tax credits.
Sales volume decreased 8% due to softer nylon end market demand, particularly in auto sector applications. The company's product mix showed Plant Nutrients as the largest segment at 38% of total sales ($156.7M), followed by Chemical Intermediates at 26% ($107.3M), Nylon at 20% ($79.5M), and Caprolactam at 16% ($66.4M).
Q2 cash flow from operations was $21.1 million, with capital expenditures of $28.3 million. The company declared a quarterly dividend of $0.16 per share, payable on August 26, 2025.
AdvanSix (NYSE: ASIX), a diversified chemistry company, has scheduled its second quarter 2025 financial results release for August 1, 2025, before the NYSE market opening. The company will host an investor conference call at 9:30 a.m. ET the same day.
Investors can participate by dialing (844) 855-9494 (domestic) or (412) 858-4602 (international). A replay will be available from 12 noon ET on August 1 until August 8. The presentation materials and live webcast will be accessible at investors.advansix.com.
AdvanSix (NYSE: ASIX) has announced it will release its first quarter 2025 financial results before the NYSE opening on Friday, May 2. The company will host an investor conference call at 9:30 a.m. ET the same day.
Investors can participate by dialing (844) 855-9494 (domestic) or (412) 858-4602 (international). A replay will be available from 12 noon ET on May 2 until May 9 via (877) 344-7529 (domestic) or (412) 317-0088 (international) with access code 5103628.
A real-time audio webcast and related materials will be accessible at http://investors.advansix.com, with presentation materials posted prior to the event.
AdvanSix (ASIX) reported Q4 2024 financial results with sales of $329 million, down 14% year-over-year, primarily due to a 16% decrease in volume. The company posted Q4 earnings per share of $0.01 and adjusted EPS of $0.09.
Full-year 2024 performance showed sales declining approximately 1%, with net income of $44.1 million, down $10.5 million from the previous year. Adjusted EBITDA reached $142.1 million, a decrease of $11.4 million, with margins at 9.4%. Cash flow from operations improved to $135.4 million.
Notable developments include claiming $9.7 million in 45Q carbon capture tax credits for 2018-2019 and receiving $5.3 million in insurance proceeds related to the 2019 PES supplier shutdown, with an additional final settlement of approximately $26 million expected in Q1 2025. The company declared a quarterly dividend of $0.16 per share, payable March 24, 2025.
AdvanSix (NYSE: ASIX), a diversified chemistry company, has announced it will release its fourth quarter and full year 2024 financial results before the New York Stock Exchange opens on Friday, February 21. The company will host an investor conference call at 9:30 a.m. ET on the same day.
Investors can participate by dialing (844) 855-9494 (domestic) or (412) 858-4602 (international). A replay will be available from 12 noon ET on February 21 until February 28, accessible via (877) 344-7529 (domestic) or (412) 317-0088 (international) with access code 6798006. Additionally, a real-time audio webcast and related materials will be available at http://investors.advansix.com.
FAQ
What is the current stock price of Advansix (ASIX)?
What is the market cap of Advansix (ASIX)?
